TG ImmunoPharma Announces FDA Clearance for Clinical Trial of TGI-6 Bispecific Antibody

HEFEI, China, June 16, 2023 /PRNewswire/ — TG ImmunoPharma Co., Ltd. (TGI), a leading biotech company focused on the development of novel immuno-oncology therapies, is pleased to announce that the FDA has granted clearance for the clinical trial of TGI-6, its groundbreaking bispecific antibody. TGI-6 targets unique tumor-associated antigens (TAA) and CD3 molecules simultaneously, enabling … Read more

Core Sound Imaging Announces Studycast & Us2.ai Partner Integration

Core Sound Imaging and Us2.ai finalize integration agreement. Us2.ai joins Studycast Integration Program, bringing AI-automated Echocardiography analysis and decision support tools  into clients’ imaging and reporting solution. Us2.ai is an FDA cleared app that reports on heart structure and function, with fully automated analyses of ALL heart chambers using both 2D and Doppler views, rendering a … Read more

Epigenetics Market size to grow by USD 1,148.2 million from 2022-2027 with 40% of the market growth originate from North America

NEW YORK, June 16, 2023 /PRNewswire/ — The epigenetics market size is expected to grow by USD 1,148.2 million during 2022-2027, progressing at a CAGR of 14.06% as per the latest Technavio market research report. North America is going to have lucrative growth during the forecast period. North America is estimated to contribute 40% of the global market during the forecast period. Technavio’s … Read more

Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

DUBLIN, June 16, 2023 /PRNewswire/ — The “Dental 3D Printing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The global dental 3D printing market size reached US$ 2.6 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 5.6 Billion by 2028, exhibiting a CAGR … Read more

Fibromyalgia Treatment Market to Reach $4.6 Billion, Globally, by 2032 at 4.0% CAGR: Allied Market Research

The fibromyalgia treatment market is experiencing growth due to several key factors, such as the significant prevalence of fibromyalgia among the population, a surge in awareness regarding fibromyalgia and its treatment, and enhanced access to generic medications for fibromyalgia treatment. PORTLAND, Ore., June 16, 2023 /PRNewswire/ — Allied Market Research published a report titled, “Fibromyalgia Treatment … Read more

The U.S. FDA Approved the Phase I/II Clinical Trial Application to Evaluate LBL-033, An Anti-MUC16/CD3 Bispecific Antibody Developed by Leads Biolabs, in Advanced Solid Tumors Including Ovarian Cancer

NANJING, China, June 16, 2023 /PRNewswire/ — Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as “Leads Biolabs” or “Company”) today announces that the phase I/II clinical trial application for LBL-033, an anti-MUC16/CD3 bispecific antibody, for the treatment of ovarian cancer and other malignant tumors, has been approved by the FDA (U.S. Food and Drug Administration). At … Read more